{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T06:45:14Z","timestamp":1774507514342,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jprasurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bjps.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:48:40Z","timestamp":1624430920000},"page":"271-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost of peripheral facial palsy treatment with Botulinum Toxin type A"],"prefix":"10.1016","volume":"75","author":[{"given":"D.","family":"Hern\u00e1ndez Herrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Abdel Muti Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"L\u00f3pez Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Alfonso Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Moraleda P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bjps.2021.06.003_bib0001","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.rh.2020.03.002","article-title":"[Satisfaction survey of patients with sequels of peripheral facial palsy treated with botulinum toxin A]","volume":"54","author":"Moraleda","year":"2020","journal-title":"Rehabilitacion (Madr)"},{"issue":"2","key":"10.1016\/j.bjps.2021.06.003_bib0002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijsu.2013.11.021","article-title":"Variability in facial palsy service provisioning in the United Kingdom","volume":"12","author":"Jing","year":"2014","journal-title":"Int J Surg"},{"issue":"11","key":"10.1016\/j.bjps.2021.06.003_bib0003","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.bjps.2017.05.048","article-title":"An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire","volume":"70","author":"Neville","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"6","key":"10.1016\/j.bjps.2021.06.003_bib0004","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/PRS.0000000000001802","article-title":"Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years","volume":"136","author":"Salles","year":"2015","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.bjps.2021.06.003_bib0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bjps.2017.01.009","article-title":"Botulinum toxin treatment for facial palsy: a systematic review","volume":"70","author":"Cooper","year":"2017","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"10.1016\/j.bjps.2021.06.003_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.fsc.2015.09.008","article-title":"Botulinum toxin in the treatment of facial paralysis","volume":"24","author":"Mehdizadeh","year":"2016","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.bjps.2021.06.003_bib0007","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/ICU.0000000000000503","article-title":"Physical therapy for facial nerve palsy: applications for the physician","volume":"29","author":"van Landingham","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.bjps.2021.06.003_bib0008","series-title":"Manual B\u00e1sico Para Residentes De Medicina F\u00edsica Y Rehabilitaci\u00f3n","first-page":"335","article-title":"Paralisis facial perif\u00e9rica","author":"Alexandres Rios de los Rios","year":"2019"},{"issue":"5","key":"10.1016\/j.bjps.2021.06.003_bib0009","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/lary.26356","article-title":"Quality of life before and after different treatment modalities in peripheral facial palsy: a systematic review","volume":"127","author":"Luijmes","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.bjps.2021.06.003_bib0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jns.2017.08.3244","article-title":"IncobotulinumtoxinA treatment of facial nerve palsy after neurosurgery","volume":"381","author":"Akulov","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bjps.2021.06.003_bib0011","article-title":"Descriptive analysis of the annual cost of treating spasticity with different types of botulinum toxin A","author":"Hern\u00e1ndez Herrero","year":"2019","journal-title":"Neurologia"},{"issue":"Suppl 4","key":"10.1016\/j.bjps.2021.06.003_bib0012","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/j.1524-4725.2010.01711.x","article-title":"Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines","volume":"36","author":"Brandt","year":"2010","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.bjps.2021.06.003_bib0013","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/DSS.0000000000001532","article-title":"Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: a Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study","volume":"44","author":"Lueangarun","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.bjps.2021.06.003_bib0014","unstructured":"ORDEN de 22 de enero de 2016, de la Consejer\u00eda de Econom\u00eda, Empleo y Hacienda, por la que se dictan Instrucciones para la Gesti\u00f3n de las N\u00f3minas del Personal de la Comunidad de Madrid para 2016., (2016)."},{"key":"10.1016\/j.bjps.2021.06.003_bib0015","series-title":"Eficacia de La Toxina Botul\u00ednica A En El Tratamiento De La Par\u00e1lisis Facial Perif\u00e9rica. Comparaci\u00f3n de Diferentes Escalas En La Evaluaci\u00f3n De La Funci\u00f3n Facial","author":"Moraleda Perez","year":"2018"},{"issue":"1","key":"10.1016\/j.bjps.2021.06.003_bib0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.anplas.2015.04.002","article-title":"Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: repartition and kinetics of doses used","volume":"61","author":"Risoud","year":"2016","journal-title":"Ann Chir Plast Esthet"},{"issue":"9","key":"10.1016\/j.bjps.2021.06.003_bib0017","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/00016489.2017.1316871","article-title":"Individualized management of facial synkinesis based on facial function","volume":"137","author":"Maria","year":"2017","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"10.1016\/j.bjps.2021.06.003_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.anplas.2015.07.011","article-title":"[Facial palsy sequel and botulinum toxin]","volume":"60","author":"Benichou","year":"2015","journal-title":"Ann Chir Plast Esthet"},{"issue":"2","key":"10.1016\/j.bjps.2021.06.003_bib0019","doi-asserted-by":"crossref","first-page":"376e","DOI":"10.1097\/PRS.0000000000002348","article-title":"Epidemiologic overview of Synkinesis in 353 Patients with longstanding facial paralysis under treatment with Botulinum toxin for 11 years","volume":"138","author":"Bennis","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.bjps.2021.06.003_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13696998.2019.1675417","article-title":"Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK","volume":"23","author":"Hollier-Hann","year":"2020","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.bjps.2021.06.003_bib0021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40120-020-00182-8","article-title":"Cost-effectiveness of incobotulinumtoxina in the treatment of sialorrhea in patients with various neurological conditions","volume":"9","author":"Makino","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.bjps.2021.06.003_bib0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40734-020-0083-0","article-title":"Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia","volume":"7","author":"Misra","year":"2020","journal-title":"J Clin Mov Disord"},{"issue":"6","key":"10.1016\/j.bjps.2021.06.003_bib0023","first-page":"810","article-title":"Long-term facial improvement after repeated BoNT-A injections and mirror biofeedback exercises for chronic facial synkinesis: a case-series study","volume":"52","author":"Mandrini","year":"2016","journal-title":"Eur J Phys Rehabil Med"},{"issue":"10","key":"10.1016\/j.bjps.2021.06.003_bib0024","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/ijd.14414","article-title":"Evaluation of the body image of patients with facial palsy before and after the application of botulinum toxin","volume":"58","author":"de Carvalho","year":"2019","journal-title":"Int J Dermatol"}],"container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681521003363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681521003363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T20:44:03Z","timestamp":1761684243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681521003363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1748681521003363"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2021.06.003","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost of peripheral facial palsy treatment with Botulinum Toxin type A","name":"articletitle","label":"Article Title"},{"value":"Journal of Plastic, Reconstructive & Aesthetic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjps.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}